deltatrials
Completed PHASE4 NCT00393367

Budesonide Inhalation Suspension for Acute Asthma in Children

Sponsor: Children's Hospital of Philadelphia

Conditions Acute Asthma Asthma Reactive Airway Exacerbation
Interventions Albuterol, ipratropium bromide Budesonide inhalation suspension (0.5 mg/2mL) 2mg, albuterol (5mg/mL) 7.5 or 10mg Ipratropium bromide Prednisolone, prednisone, or methylprednisolone
Updated 5 times since 2017 Last updated: Aug 6, 2012 Started: Dec 31, 2006 Primary completion: Nov 30, 2007 Completion: Nov 30, 2007

A PHASE4 clinical study on Acute Asthma and Asthma, this trial is completed. The trial is conducted by Children's Hospital of Philadelphia and has accumulated 5 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Children's Hospital of Philadelphia
Data source: Children's Hospital of Philadelphia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Philadelphia, United States